Teva Pharmaceutical Industries Limited (LON:0LER)

Market Cap	26.62B
Revenue (ttm)	12.48B
Net Income (ttm)	530.43M
Shares Out	n/a
EPS (ttm)	0.46
PE Ratio	50.19
Forward PE	11.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,294
Average Volume	14,908
Open	30.20
Previous Close	30.49
Day's Range	30.34 - 31.12
52-Week Range	12.50 - 31.12
Beta	n/a
RSI	84.39
Earnings Date	Jan 28, 2026

About LON:0LER

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 35,686
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0LER

Financial Performance

In 2024, LON:0LER's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD